| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | S9I9P4J8IU |
| InChI Key | JLKJXDOWBVVABZ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C22H34N5O8P |
| Molecular Weight | 527.52 |
| AlogP | 3.24 |
| Hydrogen Bond Acceptor | 13.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 11.0 |
| Polar Surface Area | 166.98 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 36.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| DISRUPTING AGENT | DNA disrupting agent | PubMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hepatitis B, Chronic | 2 | D019694 | ClinicalTrials |
| Hepatitis B, Chronic | 2 | D019694 | ClinicalTrials |
| Kidney Diseases | 1 | D007674 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1652128 |
| DrugBank | DB05020 |
| EPA CompTox | DTXSID90196062 |
| FDA SRS | S9I9P4J8IU |
| SureChEMBL | SCHEMBL4270816 |
| ZINC | ZINC000003989271 |